Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.

Sec. Clinical Infectious Diseases

Post COVID-19 era pathogen profiles and influencing factors for Hospital patients with Lower Respiratory Tract Infections in Shenzhen, China

Provisionally accepted
Tong  LiTong Li1Tiejian  FengTiejian Feng1*Dandan  NiuDandan Niu1Renli  ZhangRenli Zhang1Yongchao  GuoYongchao Guo2Yingluan  ZhangYingluan Zhang1Tengyingzi  LiuTengyingzi Liu1Peng  BoPeng Bo1Dana  HuangDana Huang1Zhen  ZhangZhen Zhang1Zhanhong  RaoZhanhong Rao1Xiaomin  ZhangXiaomin Zhang1*Xiaolu  ShiXiaolu Shi1
  • 1Shenzhen Center for Disease Control and Prevention, Shenzhen, China
  • 2Shenzhen Uni-medical Techonology Co., Ltd, Shenzhen, Shenzhen, China

The final, formatted version of the article will be published soon.

Background. Lower respiratory tract infections (LRTIs) are associated with significant morbidity, hospitalizations and mortality globally. This study aimed to investigate the causative pathogens and epidemiology characteristics of LRTIs including the factors influencing the severity of illness and the length of hospital stay (LOS). Methods. From November 2023 to June 2024, a prospective study containing 121 patients was performed at four hospitals in Shenzhen, China. The bronchoalveolar lavage fluid (BALF) samples from LRTIs inpatients were strictly collected and tested using targeted next-generation sequencing (tNGS). 108 respiratory pathogens were included in the detection list. Results. 89.3% of inpatients tested positive for one or more pathogens (108/121). The three leading pathogens were Staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa), Haemophilus influenzae (H. influenzae). Patients aged over 70 years showed the highest pathogen detection rate (23/24, 95.8%), with P. aeruginosa being the most frequently detected pathogen in this age group (9/24, 37.5%). Profound sex differences were observed in the infections of S. aeruginosa. Multiple infections were found in 53.8% of all patients group (65/121), in which 22.0% exhibited bacterial-viral co-infections (28/121). Positive interactions were identified in P. aeruginosa-A. baumannii or S. aureus. High risk factors of LOS were considerably associated with older age, multiple infections, pleural effusion, diabetes mellitus, hypertension, shortness of breath and infection with P. aeruginosa, SARS-CoV-2 or HHV. Conclusions. Different age groups of hospitalized patients showed different pathogens profiles and types of co-infection, indicating the significance of age-targeted clinical medical practice. The most common pathogens caused LRTIs were S. aureus, P. aeruginosa, H. influenzae. Older age, multiple infections, pleural effusion, diabetes mellitus, hypertension, shortness of breath and infection with P. aeruginosa, SARS-CoV-2 or HHV preferred to prolong LOS. TNGS testing should be prioritized for immunocompromised and critically ill patients.

Keywords: Lower respiratory tract infections, Bronchoalveolar Lavage Fluid, etiology, The length of hospital stay, Targeted next-generation sequencing

Received: 12 Sep 2025; Accepted: 18 Nov 2025.

Copyright: © 2025 Li, Feng, Niu, Zhang, Guo, Zhang, Liu, Bo, Huang, Zhang, Rao, Zhang and Shi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Tiejian Feng, fengtiej@126.com
Xiaomin Zhang, zxm82@qq.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.